Neuronetics Inc (STIM)
Neuronetics, Inc. is a healthcare equipment company listed on the NASDAQ under the ticker STIM. The company focuses on in-office treatments for patients with neurohealth disorders in the United States and international markets. Its main product, the NeuroStar Advanced Therapy System, is a non-invasive, office-based treatment used for adult patients with major depressive disorder. The system applies transcranial magnetic stimulation to generate pulsed magnetic fields intended to stimulate targeted areas of the brain associated with mood. Neuronetics sells its products through a direct sales and customer support organization serving psychiatrists. The company was incorporated in 2001 and is based in Malvern, Pennsylvania.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-STIM
|
$2.12
|
-27.2% Downside
|
Overvalued
|
$5.75
|
97.6% Upside
|
Bargain
|
Good
|
0.0%
|
November 10, 2026
|
12.4x
|
1.4x
|
221.7 M
|
292.8 M
|
28.1%
|
48.8%
|
-5.0
|
37.0%
|
